Venturi Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$997K Buy
1,894
+447
+31% +$251K 0.04% 227
2026
Q1
$813K Buy
1,447
+13
+0.9% +$8.34K 0.04% 234
2025
Q4
$970K Buy
1,434
+6
+0.4% +$4.09K 0.04% 202
2025
Q3
$912K Buy
1,428
+253
+22% +$154K 0.04% 209
2025
Q2
$630K Buy
+1,175
New +$562K 0.03% 284
2025
Q1
Sell
-571
Closed -$236K 1180
2024
Q4
$236K Buy
571
+470
+465% +$206K 0.01% 503
2024
Q3
$51K Buy
101
+5
+5% +$2.43K ﹤0.01% 761
2024
Q2
$46.8K Buy
96
+33
+52% +$16.6K ﹤0.01% 689
2024
Q1
$34K Buy
63
+1
+2% +$546 ﹤0.01% 594
2023
Q4
$34.4K Buy
62
+43
+226% +$20.2K ﹤0.01% 568
2023
Q3
$8.31K Hold
19
﹤0.01% 844
2023
Q2
$9.54K Buy
19
+1
+6% +$479 ﹤0.01% 660
2023
Q1
$9K Buy
+18
New +$8.61K ﹤0.01% 730

Other funds holding IDXX

Venturi Wealth Management's IDXX Position: Q2 2026 in Review

Venturi Wealth Management increased its Idexx Laboratories (IDXX) stake by 31% in Q2 2026, buying an estimated $251K and bringing the position to 1,894 shares worth $997K. The position accounts for 0.04% of the portfolio, ranked #227.

Venturi Wealth Management first reported a position in IDXX in Q1 2023 and has held it in 13 quarters since. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Venturi Wealth Management held 1,894 shares of Idexx Laboratories worth $997K as of Q2 2026.
  • Venturi Wealth Management bought 447 Idexx Laboratories shares in Q2 2026, an estimated $251K.
  • Idexx Laboratories made up 0.04% of Venturi Wealth Management's portfolio in Q2 2026, its #227 holding.
  • Venturi Wealth Management first reported a position in Idexx Laboratories in Q1 2023 and has held it in 13 quarters since.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.